Roivant becomes the fifth healthcare partner of BaselArea.swiss accelerator program joining Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer and…
Halozyme, a U.S. biotechnology company developing novel oncology and drug-delivery therapies, has established their European headquarters office in Basel, Switzerland.